DAIC

JULY 11, 2024

Heart failure (HF) is a growing worldwide public health issue affecting 64 million people annually 1 and is associated with high mortality, lower quality of life and reduced physical capacity while placing substantial costs on the healthcare system.

Heart Dysfunction 109

Heart Dysfunction Quality of Life Heart Failure Public Health 109

Science Daily - Heart Disease

JANUARY 30, 2025

Heart failure with preserved ejection function is a lethal form of heart failure, with few effective treatments. A team has now identified an enzyme, alpha-kinase 2 (ALPK2), that is specifically expressed in the heart and regulates the heart dysfunction that leads to heart failure with preserved ejection function.

Heart Failure 61

Heart Failure Heart Dysfunction 61

DAIC

FEBRUARY 27, 2024

The Aria CV Pulmonary Hypertension System is an implantable gas-filled balloon that is introduced percutaneously and functions in the main pulmonary artery to alleviate the excessive workload on the right heart that results in right heart failure. This program is intended to expedite development of novel medical devices. “We

Pulmonary 110

Pulmonary Hypertension Heart Failure Blood Pressure 110

DAIC

APRIL 6, 2024

However, researchers said the drug may be helpful in reducing heart failure risks, including hospitalization, following a heart attack. The study enrolled 6,522 people treated for acute myocardial infarction at 451 centers in 22 countries. About 32% had Type 2 diabetes.

Heart attacks 98

Heart attacks Heart Attack Heart Failure Outpatient 98

Circulation: Heart Failure

FEBRUARY 25, 2025

Circulation: Heart Failure, Ahead of Print. SERCA2a (sarco/endoplasmic reticulum Ca2+ATPase type 2a), which plays a crucial role in controlling intracellular Ca2+signaling and myocardial cell function, is downregulated and inactivated during sepsis-induced heart dysfunction.

Heart Dysfunction 40

Heart Dysfunction Heart Failure Circulation 40

DAIC

APRIL 6, 2024

While composite of death and heart failure hospitalizations was not significantly reduced, empagliflozin may help reduce heart failure risks after a heart attack, according to results from the EMPACT-MI trial presented on day one of the American College of Cardiology Scientific Sessions, ACC.24,

Heart attacks 81

Heart attacks Heart Attack Heart Failure Outcomes 81

Cardiovascular Diabetology

NOVEMBER 4, 2024

Aging is influenced by genetic determinants and comorbidities, among which diabetes increases the risk for heart failure with preserved ejection fraction. There is no therapy to prevent heart dysfunction in ag.

Preserved Ejection Fraction 52

Preserved Ejection Fraction Cardiac Function Heart Dysfunction Heart Failure 52